ECU-10869-99416
2 vaccinations
10 coded responses
21 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 290 / SC
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Pre-existing disease — Feeling: Good · HeadacheFree text: I have a PMH migraines so I get headaches often all the time. I do kot think the headache today is related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
- 2021-01-04
- 2021-01-05
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Hand dermatitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Moderate eczema to bilateral hands beginning on day 7, no prior history of eczema.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Survey response — day 0, dose 2MedDRA: Eczema — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Eczema still present from first dose, reappearwd 15 minutes before my appointment for the second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Eczema, Immediate post-injection reaction — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Still present since 1 week after first dose, new onset eczema to bilateral hands. Never had eczema prior to thisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Eczema — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Still having new onset eczema since first doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Good · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Nasal congestion, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-02-01
-
2021-02-08
Survey response — day 21, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — day 28, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
-
2021-03-01
Survey response — day 42, dose 2MedDRA: Rash — Feeling: Good · Be unable to do your normal daily activitiesFree text: RashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — 3 months, dose 2MedDRA: Skin ulcer, Tattoo associated skin reaction — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have never reacted negatively when receiving tattoos before. The two tattoos I have gotten since the vaccine have ulcerated, become open wounds, and rejected the ink.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
- 2021-07-19
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech |
Call center
4 call center cases
1 unsuccessful · 3 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I have a PMH migraines so I get headaches often all the time. I do kot think the headache today is related.
Release 1 — day 14, dose 1
Symptoms: Moderate eczema to bilateral hands beginning on day 7, no prior history of eczema.
Release 2 — day 0, dose 2
Systemic reaction (other): Eczema still present from first dose, reappearwd 15 minutes before my appointment for the second dose
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Still present since 1 week after first dose, new onset eczema to bilateral hands. Never had eczema prior to this
Systemic reaction (other): Still having new onset eczema since first dose
Systemic reaction (other): Nasal congestion, sore throat
Release 3 — day 21, dose 2
Symptoms: Runny nose
Release 4 — day 28, dose 2
Symptoms: Sore throat
Release 4 — day 42, dose 2
Symptoms: Rash
Release 7 — 3 months, dose 2
Symptoms: I have never reacted negatively when receiving tattoos before. The two tattoos I have gotten since the vaccine have ulcerated, become open wounds, and rejected the ink.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand dermatitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Skin ulcer | ✓ | ✓ | ✓ |
| SD | Tattoo associated skin reaction | ✓ | ✓ | ✓ |
| SRO | Eczema | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release